Transcript: Hello, and welcome to Certara Talks. I’m Doctor Suzanne Minton, and I’m a director of content strategy at Certara . Today, I’m talking to my colleague, doctor Joshua Apgar. Joshua, welcome to Certara talks. Would you like to introduce yourself? Sure. Thank you. I’m, Josh Apgar, one of the co founders at applied Balmain, … Continued
https://www.certara.com/video/molecular-glue-drug-development-summit-2024-recap/Create effective CRFs using our comprehensive design checklist Simple yet effective Case Report Forms (CRFs) are crucial to the success of a clinical trial. Quality CRFs reduce the chance of mistakes or ambiguity in collected data, or redundant data collection. Our CRF design checklist can help you create high quality CRFs that meet all the requirements … Continued
https://www.certara.com/fact-sheet/crf-design-checklist/How about a free demo of Pinnacle 21 Clinical Data Management & Automation Suite? Complete the form to book your no-obligation demo of Pinnacle 21… and see how you can increase the speed and quality of your clinical trial submission data! Trusted by leading drug developers
https://www.certara.com/thank-you-content-download-pinnacle-21/In this video, Dr. Mark Sullivan, Managing Director of Medicines Development for Global Health, explains how Certara’s model-informed drug development expertise was used to support developing moxidectin as a treatment for onchocerciasis “river blindness.” Transcript The role that Certara has played has really been a as an as a integral part of our drug development … Continued
https://www.certara.com/video/supporting-the-approval-of-a-treatment-for-a-neglected-tropical-disease/PRINCETON, N.J.— April 9, 2024– Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the first quarter of 2024 after the market close on Tuesday, May 7th, 2024. Company management will host a conference call to discuss financial results at 5:00PM ET. Investors interested in listening … Continued
https://www.certara.com/pressrelease/certara-to-report-first-quarter-2024-financial-results-on-may-7th-2024-and-participate-in-the-bofa-securities-healthcare-conference/The oil and gas industry has been known for its complexity and challenging operating environments, with installations all over the world, in complicated and remote locations. According to a recent Ernst & Young survey, 92% of oil and gas companies around the world are investing in AI or plan to do so in the next … Continued
https://www.certara.com/oil-and-gas/This blog reviews the role of the endogenous biomarker, CP-1, for assessing OATP1B transporter-mediated drug-drug interactions and their clinical implications.
https://www.certara.com/blog/an-endogenous-biomarker-for-predicting-oatp1b-ddis/As the clinical research industry moves towards more efficient and automated processes, clinical metadata repositories are becoming a must. You’ve probably heard of them; sometimes they are referred to as ‘clinical MDRs’ or simply ‘CMDRs’. But you might not know exactly what they do and how they can make your clinical study build more efficient. … Continued
https://www.certara.com/blog/what-should-a-clinical-metadata-repository-do/Since the FDA passed regulations requiring submitted datasets to be compliant with the CDISC Study Data Tabulation Model (SDTM), clinical trial sponsors have faced a dilemma. Should they design electronic case report forms (eCRFs) in line with SDTM from the outset? Or should they retrospectively convert data to CDISC SDTM at the end? A retrospective … Continued
https://www.certara.com/webinar/optimizing-the-quality-of-cdisc-sdtm-compliance-apac-webinar/